NCT05272618 Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries
| NCT ID | NCT05272618 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chonnam National University Hospital |
| Condition | Myocardial Infarction |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2022-02-14 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2022-02-14 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare clinical outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA) according to the coronary microvascular dysfunction (CMD), evaluated by optical coherence tomography (OCT), invasive and non-invasive coronary physiologic assessment.
Eligibility Criteria
Inclusion Criteria: * Subject with age ≥19 years and acute myocardial infarction * Rise and/or fall of cardiac troponin with one level \>99 percentile plus ischemic signs/symptoms * Subject with non-obstructive coronary arteries * \<50% diameter stenosis or * fractional flow reserve (FFR) \>0.80 ③ Subject without previous history of coronary artery disease * Subject who performed invasive coronary angiography within 24 hours after presentation ⑤ Subject who eligible for invasive and non-invasive coronary physiologic assessment Exclusion Criteria: * Subject with obstructive coronary arteries * Subject with alternate diagnosis including sepsis, pulmonary embolism, myocarditis, Takotsubo syndrome, spontaneous coronary dissection, and other cardiomyopathies. * Subject with cardiogenic shock or cardiac arrest ④ Subject who has non-cardiac co-morbid conditions with life expectancy \<1 year ⑤ Subject or lactating women ⑥ Subject unable to provide consent
Contact & Investigator
Young Joon Hong, MD, PhD
PRINCIPAL INVESTIGATOR
Chonnam National University Medical School; Chonnam National University Hospital
Frequently Asked Questions
Who can join the NCT05272618 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05272618 currently recruiting?
Yes, NCT05272618 is actively recruiting participants. Contact the research team at hyj200@hanmail.net for enrollment information.
Where is the NCT05272618 trial being conducted?
This trial is being conducted at Gwangju, South Korea.
Who is sponsoring the NCT05272618 clinical trial?
NCT05272618 is sponsored by Chonnam National University Hospital. The principal investigator is Young Joon Hong, MD, PhD at Chonnam National University Medical School; Chonnam National University Hospital. The trial plans to enroll 150 participants.